Goldline Pharmaceutical Limited (BOM:544759)
India · Delayed Price · Currency is INR 38.84
-1.55 (-3.84%)
At close: Jul 14, 2026
Goldline Pharmaceutical Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 41.17 | 28.34 | 18.06 | 2.57 | - |
Depreciation & Amortization | 2.41 | 2.5 | 1.64 | 1.75 | - |
Loss (Gain) From Sale of Assets | - | 0.91 | 0.42 | 2.04 | - |
Other Operating Activities | 16.03 | 18.35 | 21.38 | 17.28 | - |
Change in Accounts Receivable | -54.35 | -10.71 | -9.95 | -5.16 | - |
Change in Inventory | 5.65 | 7.13 | -21.2 | 0.91 | - |
Change in Accounts Payable | -2.07 | 4.13 | 7.77 | 1.07 | - |
Change in Other Net Operating Assets | 19.3 | -27.44 | 11.11 | 3.47 | - |
Operating Cash Flow | 28.15 | 23.21 | 29.22 | 23.91 | - |
Operating Cash Flow Growth | 21.25% | -20.57% | 22.21% | - | - |
Capital Expenditures | -0.57 | -2.07 | -11.09 | -11.08 | - |
Sale of Property, Plant & Equipment | - | 3.78 | - | 0.98 | - |
Investment in Securities | - | -0.09 | - | -0.25 | - |
Other Investing Activities | -0.01 | - | - | - | - |
Investing Cash Flow | -0.58 | 1.62 | -11.09 | -10.35 | - |
Short-Term Debt Issued | - | 7.64 | 0.6 | 25.96 | - |
Long-Term Debt Issued | - | - | 2.41 | - | - |
Total Debt Issued | - | 7.64 | 3.01 | 25.96 | - |
Short-Term Debt Repaid | -1.43 | - | - | - | - |
Long-Term Debt Repaid | -17.3 | -8.6 | - | -22.04 | - |
Total Debt Repaid | -18.73 | -8.6 | - | -22.04 | - |
Net Debt Issued (Repaid) | -18.73 | -0.96 | 3.01 | 3.92 | - |
Issuance of Common Stock | - | - | 4.5 | - | - |
Preferred Dividends Paid | - | -2.15 | -2.17 | -2.17 | - |
Common Dividends Paid | -2.17 | - | - | - | - |
Dividends Paid | -2.17 | -2.15 | -2.17 | -2.17 | - |
Other Financing Activities | -13.15 | -17.23 | -16.12 | -16.18 | - |
Financing Cash Flow | -34.04 | -20.34 | -10.78 | -14.43 | - |
Miscellaneous Cash Flow Adjustments | - | -0 | -0 | - | - |
Net Cash Flow | -6.47 | 4.5 | 7.36 | -0.87 | - |
Free Cash Flow | 27.58 | 21.14 | 18.14 | 12.83 | - |
Free Cash Flow Growth | 30.44% | 16.58% | 41.36% | - | - |
Free Cash Flow Margin | 8.84% | 7.54% | 7.70% | 6.46% | - |
Free Cash Flow Per Share | 4.00 | 3.06 | 3.02 | 2.14 | - |
Cash Interest Paid | - | 16.24 | 14.77 | 15.2 | - |
Cash Income Tax Paid | 9.81 | 9.13 | 1.95 | 0.35 | - |
Levered Free Cash Flow | 6.96 | 0.09 | -0.87 | -7.63 | - |
Unlevered Free Cash Flow | 15.18 | 11.64 | 8.37 | 1.97 | - |
Change in Working Capital | -31.46 | -26.89 | -12.28 | 0.28 | - |